Clinical Trials Logo

Diarrhea clinical trials

View clinical trials related to Diarrhea.

Filter by:

NCT ID: NCT01373034 Not yet recruiting - Clinical trials for Diarrhea Predominant Irritable Bowel Syndrome

The Effects of Soy Dietary Fiber in Adults With Diarrhea Predominant Irritable Bowel Syndrome

Start date: July 2011
Phase: N/A
Study type: Interventional

The investigators will evaluate the efficacy of soy dietary fiber in adults with diarrhea predominant irritable bowel syndrome.

NCT ID: NCT01371656 Completed - Diarrhea Clinical Trials

Levofloxacin in Preventing Infection in Young Patients With Acute Leukemia Receiving Chemotherapy or Undergoing Stem Cell Transplantation

Start date: September 2011
Phase: Phase 3
Study type: Interventional

This randomized phase III trial studies how well levofloxacin works in preventing infection in young patients with acute leukemia receiving chemotherapy or undergoing stem cell transplant. Giving antibiotics may be effective in preventing or controlling early infection in patients receiving chemotherapy or undergoing stem cell transplant for acute leukemia. It is not yet known whether levofloxacin is effective in preventing infection.

NCT ID: NCT01358708 Terminated - Clinical trials for Diarrhea-predominant Irritable Bowel Syndrome

Treatment of Diarrhea-predominant Irritable Bowel Syndrome (IBS-D) With LACTEOL® 340 mg

Start date: June 2010
Phase: Phase 3
Study type: Interventional

Irritable bowel syndrome is a complex condition with a high unmet medical need for effective and safe treatment options. Lacteol® is a lactobacillus product used for adjunctive and symptomatic treatment of diarrhea. In this study, Lacteol® 340 mg will be evaluated as a potential therapy for the treatment of diarrhea-predominant irritable bowel syndrome (IBS-D).

NCT ID: NCT01350570 Completed - Clinical trials for Diarrhea-predominant Irritable Bowel Syndrome

Acupuncture for Patients With Diarrhea-predominant IBS or Functional Diarrhea: a Randomized Controlled Trial

Start date: August 2011
Phase: Phase 2/Phase 3
Study type: Interventional

This trial is to assess the effectiveness of three types of acupuncture for patients with functional diarrhea comparing to a positive drug control.

NCT ID: NCT01326338 Completed - Diarrhea Clinical Trials

Nitazoxanide for the Treatment of Prolonged Diarrhea in Children

Start date: March 2005
Phase: Phase 3
Study type: Interventional

The purpose of this study was to determine the efficacy of nitazoxanide suspension compared to placebo in treating prolonged diarrhea in children.

NCT ID: NCT01316718 Completed - Clinical trials for Irritable Bowel Syndrome With Diarrhoea

Mesalazine for the Treatment of Diarrhoea-predominant Irritable Bowel Syndrome (IBS-D)

MIBS
Start date: March 2011
Phase: Phase 4
Study type: Interventional

The purpose of the trial is to define the clinical benefit and possible mediators of the benefit of mesalazine in Irritable Bowel Syndrome (IBS) with diarrhoea. The investigators will therefore evaluate symptoms (primarily bowel frequency) and markers reflecting mast cell activation and small bowel tone.

NCT ID: NCT01306383 Completed - Diarrhoea Clinical Trials

Solar Disinfection (SODIS) of Drinking Water for Use in Developing Countries or in Emergency Situations

SODISWATER
Start date: June 2008
Phase: N/A
Study type: Interventional

SODISWATER was a health impact assessment study investigating the effect of sunlight to inactivate microbial pathogens in drinking water. This study was carried out by observing whether children younger than 5 years old who drink solar disinfected water were healthier than those who did not. Health was measured by how often the children had diarrhoea or dysentery. Caregivers for the participants were given plastic bottles to place in the sun, water samples were then collected from these plastic bottles to be analyzed. They were also requested to fill in diarrhea diaries. TESTABLE RESEARCH HYPOTHESES: Health Impact Assessment: Children who use solar disinfected water will have: (a) lower morbidity due to non-bloody diarrhoea and bloody diarrhoea (c) increased growth rates (d) lower mortality (e) increased family productivity (f) decreased care-giver burden (g) increased school attendance

NCT ID: NCT01306097 Completed - Diarrhea Clinical Trials

Zinc Supplementation and Severe and Recurrent Diarrhea

Start date: January 2009
Phase: N/A
Study type: Interventional

Evaluating the impact of 3 months daily zinc supplementation on incidence of severe and recurrent diarrhea in 6 to 36 months age children in Bandarabbaas

NCT ID: NCT01303224 Completed - Clinical trials for Irritable Bowel Syndrome With Diarrhea

Ibodutant for Relief of Irritable Bowel Syndrome With Diarrhoea (IBS-D)

IRIS-2
Start date: October 2010
Phase: Phase 2
Study type: Interventional

Irritable Bowel Syndrome with diarrhoea (IBS-D) is a functional gastrointestinal disorder characterised by chronic or recurrent abdominal pain or discomfort and diarrhoea. This trial aims at the evaluation of the efficacy and safety of the neurokinin type 2 receptor antagonist Ibodutant in improving IBS-D symptoms.

NCT ID: NCT01295918 Completed - Clinical trials for Clostridium Difficile Infection

Probiotic Lactobacillus Reuteri to Prevent Antibiotic-associated Diarrhea and Clostridium Difficile-related Infections in Hospitalized Children

AADreuter
Start date: February 2011
Phase: Phase 3
Study type: Interventional

The purpose of this study is to determine if the daily intake of the probiotic Lactobacillus reuteri prevents antibiotic-associated diarrhoea and related Clostridium difficile infections in children and adolescents.